Regentatlantic Capital LLC Bristol Myers Squibb CO Transaction History

Regentatlantic Capital LLC

  • $3.34 Billion
  • Q3 2022

A detailed history of Regentatlantic Capital LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Regentatlantic Capital LLC holds 107,166 shares of BMY stock, worth $5.78 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares
107,166
Previous 104,074 2.97%
Holding current value
$5.78 Million
Previous $8.01 Million 4.94%
% of portfolio
0.23%
Previous 0.26%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$0.13 - $76.84 $401 - $237,589
3,092 Added 2.97%
107,166 $7.62 Million
Q2 2022

Aug 15, 2022
BUY
$72.62 - $79.98 $213,430 - $235,061
2,939 Added 2.91%
104,074 $8.01 Million
Q1 2022

May 02, 2022
BUY
$61.48 - $73.72 $1.13 Million - $1.36 Million
18,453 Added 22.32%
101,135 $7.39 Million
Q4 2021

Jan 27, 2022
SELL
$53.63 - $62.52 $665,387 - $775,685
-12,407 Reduced 13.05%
82,682 $5.16 Million
Q3 2021

Nov 15, 2021
BUY
$59.17 - $69.31 $703,235 - $823,749
11,885 Added 14.28%
95,089 $5.63 Million
Q2 2021

Aug 12, 2021
BUY
$61.91 - $67.42 $302,677 - $329,616
4,889 Added 6.24%
83,204 $5.56 Million
Q1 2021

Apr 29, 2021
BUY
$59.34 - $66.74 $387,964 - $436,346
6,538 Added 9.11%
78,315 $4.94 Million
Q4 2020

Feb 04, 2021
BUY
$57.74 - $65.43 $8,430 - $9,552
146 Added 0.2%
71,777 $4.45 Million
Q3 2020

Oct 13, 2020
SELL
$57.43 - $63.64 $198,937 - $220,448
-3,464 Reduced 4.61%
71,631 $4.32 Million
Q2 2020

Aug 13, 2020
BUY
$54.82 - $64.09 $637,337 - $745,110
11,626 Added 18.32%
75,095 $4.42 Million
Q1 2020

May 14, 2020
BUY
$46.4 - $67.43 $686,024 - $996,952
14,785 Added 30.37%
63,469 $3.54 Million
Q4 2019

Feb 04, 2020
BUY
$49.21 - $64.19 $1.33 Million - $1.74 Million
27,047 Added 125.0%
48,684 $3.13 Million
Q3 2019

Oct 22, 2019
BUY
$42.77 - $50.71 $215,731 - $255,781
5,044 Added 30.4%
21,637 $1.1 Million
Q2 2019

Jul 23, 2019
SELL
$44.62 - $49.34 $67,911 - $75,095
-1,522 Reduced 8.4%
16,593 $752,000
Q1 2019

May 03, 2019
SELL
$45.12 - $53.8 $21,702 - $25,877
-481 Reduced 2.59%
18,115 $864,000
Q4 2018

Jan 30, 2019
SELL
$48.76 - $63.23 $31,206 - $40,467
-640 Reduced 3.33%
18,596 $967,000
Q3 2018

Oct 30, 2018
BUY
$55.19 - $62.25 $238,034 - $268,484
4,313 Added 28.9%
19,236 $1.19 Million
Q2 2018

Jul 31, 2018
SELL
$50.53 - $62.98 $17,685 - $22,043
-350 Reduced 2.29%
14,923 $826,000
Q1 2018

Apr 23, 2018
SELL
$59.92 - $68.98 $26,125 - $30,075
-436 Reduced 2.78%
15,273 $966,000
Q4 2017

Jan 23, 2018
BUY
$59.94 - $65.35 $37,342 - $40,713
623 Added 4.13%
15,709 $963,000
Q3 2017

Oct 25, 2017
BUY
$55.23 - $63.74 $833,199 - $961,581
15,086
15,086 $962,000

Others Institutions Holding BMY

# of Institutions
2,729
Shares Held
1.57B
Call Options Held
30M
Put Options Held
31.7M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $115B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Regentatlantic Capital LLC Portfolio

Follow Regentatlantic Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Regentatlantic Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Regentatlantic Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email